Back

Pharmacogenetic testing to broaden patient eligibility for mavacamten

European Heart Journal - Cardiovascular Pharmacotherapy

14 November 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY Chronic Heart Failure

Contributors

Lorenz Van der Linden
Lorenz Van der Linden

Author

University Hospitals (UZ) Leuven Leuven , Belgium

Lucas Van Aelst
Lucas Van Aelst

Author

Iacopo Olivotto
Iacopo Olivotto

Author

University of Florence Florence , Italy

You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources